Change Agents Corp. (CHGA) Stock Analysis & Investment Frameworks
Change Agents Corp. (CHGA) stock analysis on Invetso. Review Change Agents Corp.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Change Agents Corp. Company Overview
- Exchange: NASDAQ
- Sector: Technology
- Industry: Software - Application
- Country: US
Change Agents Corp. Key Financial Metrics
- Market Cap: $1.66M
- Revenue: $N/A
- ROE: -135.36%
- ROIC: -72.94%
- Dividend Yield: N/A
About Change Agents Corp.
Change Agents Corporation, together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. The company was formerly known as Avalon GloboCare Corp. and changed its name to Change Agents Corporation in July 2026. Change Agents Corporation was founded in 2015 and is headquartered in Freehold, New Jersey.
Change Agents Corp. Investment Frameworks
Invetso analyzes Change Agents Corp. (CHGA) across the following frameworks:
- Change Agents Corp. 10Y Growth Potential
- Change Agents Corp. Scenario Analysis
- Change Agents Corp. Risks & Opportunities
- Change Agents Corp. Economic Moat
- Change Agents Corp. Business Model
- Change Agents Corp. Management
- Change Agents Corp. SWOT Analysis
- Change Agents Corp. Porter's 5 Forces
- Change Agents Corp. PESTLE Analysis
- Change Agents Corp. ESG Analysis
